Maughan, T. S., Adams, R. A., Smith, C. G., Meade, A. M., Seymour, M. T., Wilson, R. H., . . . Cheadle, J. P. (2011). Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: Results of the randomised phase 3 MRC COIN trial. Lancet Publishing Group.
Chicago Style CitationMaughan, Timothy S., et al. Addition of Cetuximab to Oxaliplatin-based First-line Combination Chemotherapy for Treatment of Advanced Colorectal Cancer: Results of the Randomised Phase 3 MRC COIN Trial. Lancet Publishing Group, 2011.
MLA CitationMaughan, Timothy S., et al. Addition of Cetuximab to Oxaliplatin-based First-line Combination Chemotherapy for Treatment of Advanced Colorectal Cancer: Results of the Randomised Phase 3 MRC COIN Trial. Lancet Publishing Group, 2011.